logo
episode-header-image
Oct 2023
18m 42s

Episode 078: Management of relapsed diff...

Rouleaux University Medical Center
About this episode
In this FINAL episode of our DLBCL series, we build on our conversation from last week, focusing on the management of relapsed DLBCL. If you have not done so already, we recommend you check out Episode 077! Content: - Treatment with selective antibodies against CD19 - How to approach relapsed disease after CAR-T - Use of BiTE therapy - Role of allo? * ... Show More
Up next
Oct 7
Episode 166: Pancreatic Cancer Series, Pt. 1 – Biology, Diagnosis, and Staging
This week we kick off a brand-new series on pancreatic cancer, starting with the fundamentals. Using the case of a 68-year-old man with painless jaundice, weight loss, and new-onset diabetes, we cover the epidemiology and sobering survival statistics of pancreatic ductal adenocar ... Show More
28m 52s
Sep 23
Episode 165: CLL Updates Series, Pt. 2 – Relapsed/Refractory in 2026
This week we wrap up our two-part CLL update by turning to relapsed and refractory disease. We pick up with the 68-year-old man from Part 1, now a year out from frontline therapy and showing signs of relapse. We cover when relapse actually needs treatment, the history of BTK inhi ... Show More
22m 22s
Sep 16
Episode 164: CLL Updates Series, Pt. 1 – Frontline Therapy in 2026
This week we kick off a two-part update to our CLL series, covering what has changed in frontline management since our original episodes. Using the case of a 68-year-old man with newly diagnosed, symptomatic CLL, we revisit the essential steps before treatment: confirming an indi ... Show More
26m 2s
Recommended Episodes
May 2023
Multiple Myeloma
<p>This week’s episode is part 2 of our plasma cell dyscrasias series. We will go over the important details on risk stratification, as well as initial and relapse treatment options for Multiple Myeloma, with key details on the pharmacology of myeloma drugs.</p><p><br/></p> 
16m 47s
Aug 2024
EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway
<p>How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024.<br />   <br /> Credit available for this activity expires: 07/31/25<br /> Earn Credit / Learning Obje ... Show More
37m 22s
Dec 2023
Follicular Lymphoma
<p>This week’s episode will be focusing on one of the Non-Hodgkin Lymphomas: Follicular Lymphoma. We will go over the important details on diagnostic criteria, indications for treatment and treatment options.</p> 
12 m
Jul 2020
Chapter 11: Hematology and Oncology (Part 7)
In the final episode from the Hematology and Oncology chapter of Crush Step 1, we discuss: - Myeloproliferative Disorders - Disorders of Heme Production - Pharmacologic Treatment Learn more about your ad choices. Visit megaphone.fm/adchoices 
50m 21s
Aug 2025
Episode 64. Lymphoma Updates from EHA and ICML 2025 with Dr. Adrian Minson
In this episode of Blood Cancer Talks, we have Dr. Adrian Minson from the Peter MacCallum Cancer Centre to discuss the latest developments in lymphoma presented at the recent EHA and ICML meetings in June 2025. The episode focuses primarily on the emerging role of bispecific anti ... Show More
43m 3s
Nov 2025
Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions
In this week's episode, Blood editor Dr. Laura Michaelis interviews author Dr. Taylor Brooks on his latest paper published in volume 146 issue 18 of Blood Journal. The conversation discusses outcomes of bispecific antibodies (epcoritamab or glofitamab) in treating aggressive B-ce ... Show More
9m 36s
Dec 2019
Sneak Peek Episode 2
This episode highlights articles and commentaries that help expand our understanding of prognostic biomarkers in CLL, learn more about a streamlined analysis of the granulocyte transcriptome in myeloproliferative neoplasms, explore the role of neutrophil extra cellulartraps in ad ... Show More
19m 14s
Sep 2023
Lymphoma (2nd edition)
<p>This episode covers lymphoma.<br/><br/>Written notes can be found at <a href='https://zerotofinals.com/medicine/haematology/lymphoma/'>https://zerotofinals.com/medicine/haematology/lymphoma/</a> or in the haematology section of the 2nd edition of the Zero to Finals medicine bo ... Show More
6m 45s
Oct 2024
Outdated: Cervix Part 2: Locally Advanced Cervical Cancer
This is the second of three episodes covering cervical cancer. In this episode, we define locally advanced, metastatic, and recurrent cervical cancer. We will discuss the standard treatment options, including chemotherapy and immunotherapy choices. Join us for bi-weekly episodes ... Show More
39m 43s
May 2023
74: 2 Fast 2 Feverish: Late ID Complications of CAR-T therapy
In Part 2 of this pair of episodes, Drs. Rita Dib and Joseph Sassine zoom through the late infectious complications of CAR-T cell therapy.Episodes | Consult Notes | Subscribe | Twitter | Merch | febrilepodcast@gmail.com 
46m 18s